Atlas Trials

Effect of Low-dose Intracoronary Reteplase on Myocardial Infarct Size During Primary Percutaneous Coronary Intervention

Clinical trial NCT04571580 · TERMINATED

Trial details

NCT number
NCT04571580
Sponsor
Ge Junbo
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Acute ST-segment Elevation Myocardial Infarction
Start date
2021-07-01
Primary completion
2023-01-31
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.